{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T06:02:09Z","timestamp":1703224929565},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,12,18]],"date-time":"2008-12-18T00:00:00Z","timestamp":1229558400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s00120-008-1758-6","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T12:41:34Z","timestamp":1229431294000},"page":"37-45","source":"Crossref","is-referenced-by-count":7,"title":["Stellenwert der Lymphadenektomie beim Prostatakarzinom"],"prefix":"10.1007","volume":"48","author":[{"given":"T.","family":"Schlomm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"B\u00f6rgermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Heinzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"R\u00fcbben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Huland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Graefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,18]]},"reference":[{"key":"1758_CR1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.juro.2006.09.053","volume":"177","author":"Berglund","year":"2007","unstructured":"Berglund RK, Sadetsky N, DuChane J et al (2007) Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE. J Urol 177: 526\u2013530","journal-title":"J Urol"},{"key":"1758_CR2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.urology.2003.09.064","volume":"63","author":"Bhatta-Dhar","year":"2004","unstructured":"Bhatta-Dhar N, Reuther AM, Zippe C, Klein EA (2004) No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer. Urology 63: 528\u2013531","journal-title":"Urology"},{"key":"1758_CR3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/01.ju.0000155533.93528.4c","volume":"173","author":"DiMarco","year":"2005","unstructured":"DiMarco DS, Zincke H, Sebo TJ et al (2005) The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol 173: 1121\u20131125","journal-title":"J Urol"},{"key":"1758_CR4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/01.ju.0000049032.38743.c7","volume":"169","author":"Bader","year":"2003","unstructured":"Bader P, Burkhard FC, Markwalder R, Studer UE (2003) Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169: 849\u2013854","journal-title":"J Urol"},{"key":"1758_CR5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.juro.2007.05.048","volume":"178","author":"Boorjian","year":"2007","unstructured":"Boorjian SA, Thompson RH, Siddiqui S et al (2007) Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol 178: 864\u2013871","journal-title":"J Urol"},{"key":"1758_CR6","first-page":"95","volume":"Urol","author":"Briganti","year":"2008","unstructured":"Briganti AJK, Da Pozzo L, Gallina A et al (2008) Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. a new proposal based on a two institution experience on 784 consecutive n+ patients. Eur Urol (Suppl 6): 95","journal-title":"Eur"},{"key":"1758_CR7","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1097\/01.ju.0000143448.04161.cc","volume":"172","author":"Daneshmand","year":"2004","unstructured":"Daneshmand S, Quek ML, Stein JP et al (2004) Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 172: 2252\u20132255","journal-title":"J Urol"},{"key":"1758_CR8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.eururo.2008.05.023","volume":"54","author":"Schumacher","year":"2008","unstructured":"Schumacher MC, Burkhard FC, Thalmann GN et al (2008) Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol 54: 344\u2013352","journal-title":"Eur Urol"},{"key":"1758_CR9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/1097-0142(20010101)91:1<66::AID-CNCR9>3.0.CO;2-P","volume":"91","author":"Cheng","year":"2001","unstructured":"Cheng L, Zincke H, Blute ML et al (2001) Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 91: 66\u201373","journal-title":"Cancer"},{"key":"1758_CR10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1097-0045(20000301)42:4<247::AID-PROS1>3.0.CO;2-5","volume":"42","author":"Dennis","year":"2000","unstructured":"Dennis LK, Resnick MI (2000) Analysis of recent trends in prostate cancer incidence and mortality. Prostate 42: 247\u2013252","journal-title":"Prostate"},{"key":"1758_CR11","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.urology.2007.06.1119","volume":"70","author":"Desireddi","year":"2007","unstructured":"Desireddi NV, Roehl KA, Loeb S et al (2007) Improved stage and grade-specific progression-free survival rates after radical prostatectomy in the PSA era. Urology 70: 950\u2013955","journal-title":"Urology"},{"key":"1758_CR12","doi-asserted-by":"crossref","unstructured":"Briganti A, Karnes RJ, Da Pozzo LF et al (2008) Development and internat validation of the first nomoram predicting long-term prostate cancer specific survival in patients with node positive prostate cancer treated with radical prostatectomy and pelvic lymph node dissection. J Urol (Epub ahead of print)","DOI":"10.1016\/S0022-5347(08)60725-9"},{"key":"1758_CR13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(06)70700-8","volume":"7","author":"Messing","year":"2006","unstructured":"Messing EM, Manola J, Yao J et al (2006) Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol 7: 472\u2013479","journal-title":"Lancet Oncol"},{"key":"1758_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eururo.2007.09.017","volume":"53","author":"Klein","year":"2008","unstructured":"Klein EA, Kattan M, Stephenson A, Vickers A (2008) How many lymphadenectomies does it take to cure one patient? Eur Urol 53: 13\u201320","journal-title":"Eur Urol"},{"key":"1758_CR15","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"D","year":"1998","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280: 969\u2013974","journal-title":"JAMA"},{"key":"1758_CR16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.urology.2007.08.027","volume":"71","author":"Weight","year":"2008","unstructured":"Weight CJ, Reuther AM, Gunn PW et al (2008) Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancer. Urology 71: 141\u2013145","journal-title":"Urology"},{"key":"1758_CR17","unstructured":"Haese A, Gallina A, Walz J et al (2007) No differences in biochemical recurrence between N0 and Nx patients subjected to radical prostatectomy: A matched analyses on 5977 patients. J Urol (Suppl 4): 108"},{"key":"1758_CR18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0022-5347(06)00574-X","volume":"176","author":"Burkhard","year":"2006","unstructured":"Burkhard FC, Kessler TM, Fleischmann A et al (2006) Nerve sparing open radical retropubic prostatectomy\u2013does it have an impact on urinary continence? J Urol 176: 189\u2013195","journal-title":"J Urol"},{"key":"1758_CR19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1569-9056(08)60138-4","volume":"54","author":"Briganti","year":"2008","unstructured":"Briganti A, Da Pozzo L, Suardi N et al (2008) Is extended pelvic lymph node dissection justified in patients with low risk prostate cancer? Eur Urol 54(Suppl 7): 105","journal-title":"Eur Urol"},{"key":"1758_CR20","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.eururo.2006.01.043","volume":"49","author":"Briganti","year":"2006","unstructured":"Briganti A, Chun FK, Salonia A et al (2006) Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 49: 1019\u20131027","journal-title":"Eur Urol"},{"key":"1758_CR21","doi-asserted-by":"crossref","unstructured":"Chun FK, Suardi N, Capitanio U et al (2008) Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy. Eur Urol (Epub ahead of print)","DOI":"10.1016\/j.eururo.2008.04.099"},{"key":"1758_CR22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/end.2007.0219","volume":"22","author":"Karakiewicz","year":"2008","unstructured":"Karakiewicz PI, Chun FK, Gallina A et al (2008) Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum. J Endourol 22: 533\u2013538","journal-title":"J Endourol"},{"key":"1758_CR23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-5347(05)64055-4","volume":"169","author":"Clark","year":"2003","unstructured":"Clark T, Parekh DJ, Cookson MS et al (2003) Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 169: 145\u2013147 (discussion 7-8)","journal-title":"J Urol"},{"key":"1758_CR24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.eururo.2007.09.002","volume":"53","author":"Heidenreich","year":"2008","unstructured":"Heidenreich A, Aus G, Bolla M et al (2008) EAU guidelines on prostate cancer. Eur Urol 53: 68\u201380","journal-title":"Eur Urol"},{"key":"1758_CR25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eururo.2007.04.020","volume":"52","author":"Heidenreich","year":"2007","unstructured":"Heidenreich A, Ohlmann CH, Polyakov S (2007) Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy. Eur Urol 52: 29\u201337","journal-title":"Eur Urol"},{"key":"1758_CR26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.urology.2006.01.055","volume":"68","author":"Joslyn","year":"2006","unstructured":"Joslyn SA, Konety BR (2006) Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 68: 121\u2013125","journal-title":"Urology"},{"key":"1758_CR27","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1097\/01.ju.0000140912.45821.1d","volume":"172","author":"Allaf","year":"2004","unstructured":"Allaf ME, Palapattu GS, Trock BJ et al (2004) Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 172: 1840\u20131844","journal-title":"J Urol"},{"key":"1758_CR28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1464-410X.1996.00841.x","volume":"78","author":"Gil-Vernet","year":"1996","unstructured":"Gil-Vernet JM (1996) Prostate cancer: anatomical and surgical considerations. Br J Urol 78: 161\u2013168","journal-title":"Br J Urol"},{"key":"1758_CR29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2007.07.035","volume":"53","author":"Mattei","year":"2008","unstructured":"Mattei A, Fuechsel FG, Bhatta Dhar N et al (2008) The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol 53: 118\u2013125","journal-title":"Eur Urol"},{"key":"1758_CR30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0022-5347(17)56906-2","volume":"121","author":"Golimbu","year":"1979","unstructured":"Golimbu M, Morales P, Al-Askari S, Brown J (1979) Extended pelvic lymphadenectomy for prostatic cancer. J Urol 121: 617\u2013620","journal-title":"J Urol"},{"key":"1758_CR31","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0022-5347(05)65177-4","volume":"167","author":"Heidenreich","year":"2002","unstructured":"Heidenreich A, Varga Z, Von Knobloch R (2002) Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167: 1681\u20131686","journal-title":"J Urol"},{"key":"1758_CR32","first-page":"280","volume":"Urol","author":"Heidenreich","year":"2006","unstructured":"Heidenreich A, Ohlmann CH, Engelmann UH et al (2006) Partin tables do not adequately predict the risk of lymph node involvement in patients undergoing radical prostatectomy for clinical localized prostate cancer. Eur Urol (Suppl 5): 280","journal-title":"Eur"},{"key":"1758_CR33","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.eururo.2006.08.015","volume":"50","author":"Briganti","year":"2006","unstructured":"Briganti A, Chun FK, Salonia A et al (2006) Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 50: 1006\u20131013","journal-title":"Eur Urol"},{"key":"1758_CR34","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.juro.2007.10.072","volume":"179","author":"Musch","year":"2008","unstructured":"Musch M, Klevecka V, Roggenbuck U, Kroepfl D (2008) Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006. J Urol 179: 923\u2013928, discussion 8\u20139","journal-title":"J Urol"},{"key":"1758_CR35","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/jnci\/dji248","volume":"97","author":"Albertsen","year":"2005","unstructured":"Albertsen PC, Hanley JA, Barrows GH et al (2005) Prostate cancer and the will rogers phenomenon. J Natl Cancer Inst 97: 1248\u20131253","journal-title":"J Natl Cancer Inst"},{"key":"1758_CR36","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0360-3016(03)00268-2","volume":"56","author":"Chism","year":"2003","unstructured":"Chism DB, Hanlon AL, Troncoso P et al (2003) The gleason score shift: score four and seven years ago. Int J Radiat Oncol Biol Phys 56: 1241\u20131247","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1758_CR37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.juro.2007.08.125","volume":"179","author":"Gofrit","year":"2008","unstructured":"Gofrit ON, Zorn KC, Steinberg GD et al (2008) The Will Rogers phenomenon in urological oncology. J Urol 179: 28\u201333","journal-title":"J Urol"},{"key":"1758_CR38","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/jnci\/dji286","volume":"97","author":"Thompson","year":"2005","unstructured":"Thompson IM, Canby-Hagino E, Lucia MS (2005) Stage migration and grade inflation in prostate cancer: Will Rogers meets Garrison Keillor. J Natl Cancer Inst 97: 1236\u20131237","journal-title":"J Natl Cancer Inst"},{"key":"1758_CR39","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.juro.2007.03.003","volume":"177","author":"Thompson","year":"2007","unstructured":"Thompson I, Thrasher JB, Aus G et al (2007) Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 177: 2106\u20132131","journal-title":"J Urol"},{"key":"1758_CR40","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0022-5347(17)39759-8","volume":"144","author":"Steinberg","year":"1990","unstructured":"Steinberg GD, Epstein JI, Piantadosi S, Walsh PC (1990) Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987. J Urol 144: 1425\u20131432","journal-title":"J Urol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-008-1758-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-008-1758-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-008-1758-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T06:58:52Z","timestamp":1558594732000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-008-1758-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,18]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["1758"],"URL":"https:\/\/doi.org\/10.1007\/s00120-008-1758-6","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,18]]}}}